Literature DB >> 1814037

Twenty-year follow-up of 160 patients with ataxia-telangiectasia.

F Ersoy1, A I Berkel, O Sanal, H Oktay.   

Abstract

The clinical and immunological findings of 160 patients diagnosed over a period of twenty years as having ataxia-telangiectasia (AT) are presented. The study group composed of 68 females and 92 males were members of 117 families. The rate of parental consanguinity was 65 percent. The incidence of AT in 117 families was 36.6 percent. All patients had the characteristic facial and postural features of AT. The mean duration of follow-up of 160 patients was 6.35 years. Fifty patients had died during the follow-up (36 of pulmonary infections, 14 of malignancies). Somatic growth retardation was a prominent feature. Recurrent sinopulmonary infections were detected in 66 percent of patients. Two patients had hypothyroidism, one had diabetes mellitus, and one had both conditions. The incidence of malignancies was found to be 2.3 percent in the immediate relatives of the patients. The total lymphocyte count was low in 57 percent, and skin tests to PHA, candida, PPD and SK-SD were negative in 17.7%, 72.6%, 43.6%, and 78.2% of patients, respectively. In vitro blastogenic response to PHA was low in 61 percent of patients. The mean value of E-rosette formation was significantly lower than control values. Six patients had low serum IgG levels. The serum IgM level was high in 26.6 percent of patients and the IgA level was low or absent in 51.3 percent. There was no correlation between immune disturbance and duration of illness.

Entities:  

Mesh:

Year:  1991        PMID: 1814037

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  6 in total

1.  Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia.

Authors:  O Sanal; F Ersoy; L Yel; I Tezcan; A Metin; H Ozyürek; S Gariboglu; S Fikrig; A I Berkel; G T Rijkers; B J Zegers
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

2.  Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort.

Authors:  Andreea Nissenkorn; Yael Levy-Shraga; Yonit Banet-Levi; Avishay Lahad; Ifat Sarouk; Dalit Modan-Moses
Journal:  Pediatr Res       Date:  2016-02-18       Impact factor: 3.756

Review 3.  Laboratory evaluation of primary immunodeficiencies.

Authors:  João B Oliveira; Thomas A Fleisher
Journal:  J Allergy Clin Immunol       Date:  2009-12-29       Impact factor: 10.793

4.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

5.  Elevated IgM levels as a marker for a unique phenotype in patients with Ataxia telangiectasia.

Authors:  Alexander Krauthammer; Avishay Lahad; Lior Goldberg; Ifat Sarouk; Batia Weiss; Raz Somech; Michalle Soudack; Itai M Pessach
Journal:  BMC Pediatr       Date:  2018-06-04       Impact factor: 2.125

6.  Growth in ataxia telangiectasia.

Authors:  Valerie A I Natale; Tim J Cole; Cynthia Rothblum-Oviatt; Jennifer Wright; Thomas O Crawford; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Haley Schlechter; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2021-03-10       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.